Research Article

Hepatitis E rORF2p Stimulated and Unstimulated Peripheral Expression Profiling in Patients with Self-Limiting Hepatitis E Infection

Table 2

Gene expression quantified using TaqMan Low Density Arrays and normalized with respective controls.

AVH-E ( )Recovered ( ) HEV-specific gene expression
Gene ID and nameFold change (Mean ± SD)AVH-E ( )Recovered ( )
72 hrs

Th1/anti-inflammatory cytokines
 IL2
 IFN-
 TGF 1
 IL10
 IL2R (CD25)
Th2/proinflammatory cytokines
 IL4
 IL6
 TNF
 IL17A
Ectonucleotidase
 ENTPD1 (CD39)
 NT5E (CD73)
Apoptotic/inhibitory
 Fas/Apo-1 (CD95)
 CTLA-4 (CD152)
 PD1 (CD279)
 PD1-L (CD274)
 GITR (CD357)
Costimulatory
 CD40 (CD154)
 CD70 (CD27L)
 ICOS (CD278)
 4-1BB (CD137)
Activation molecules
 CD69
 TFRC (CD71)
Chemokine and homing receptors
 SELL (CD62L)
E 7 (CD103)
 CCR4 (CD194)
 CCR7 (CD197)

In unstimulated PBMCs of AVH-E and recovered individuals, mean fold changes are compared after normalization with healthy control data. HEV rORF2p stimulated in  vitro cultured PBMCs gene expression pattern after normalization with in  vitro cultured unstimulated PBMCs from respective groups (bold). The values shown are the mean fold change compared with unstimulated/stimulated cells of respective groups and are expressed in mean ± standard deviation.